NDC 70518-4516-01 - Lisinopril and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4516
- Requested NDC
- 70518-4516-01
- Package NDCs from labels
- 70518-4516-0, 70518-4516-1, 70518-4516-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-09-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, USP for oral use Rx Only | REMEDYREPACK INC. | 2026-09-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4516-0 | Lisinopril and Hydrochlorothiazide | 30 in 1 BLISTER PACK | TABLET | 30 | 2 | |
| 70518-4516-1 | Lisinopril and Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | bb362b67-4a14-4491-9e12-0f7d5c7a65bc | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | de2d4628-08b3-4e31-aacc-ed85897f52e3 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 89f525cb-fa15-4407-8cbf-14e7f6bf9055 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 0dbc5ebb-99ab-428d-b9b3-cd7a68dd948a | 2026-02-04 | Warnings, Adverse reactions | 0J48LPH2TH |
| lisinopril | LISINOPRIL | Bryant Ranch Prepack | d8a0c806-8f5e-41c0-91c6-ad267af27a53 | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| BIS II Tooth | PRECIPITATED CALCIUM CARBONATE, TOCOPHEROL ACETATE, ALUMINIUM CHLOROHYDROXY ALLANTOINATE, DIBASIC CALCIUM PHOSPHATE HYDRATE | Jewoo Medical CO.,LTD | 49e5eeaa-7506-f42a-e063-6294a90a2864 | 2026-02-03 | Warnings | O7TSZ97GEP |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | de815d64-b8d4-46a8-95b8-c230abe7f767 | 2026-02-03 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| BIS II Tooth | PRECIPITATED CALCIUM CARBONATE, TOCOPHEROL ACETATE, ALUMINIUM CHLOROHYDROXY ALLANTOINATE, DIBASIC CALCIUM PHOSPHATE HYDRATE | Jewoo Medical CO.,LTD | 49f94296-3e74-1828-e063-6394a90a97d5 | 2026-02-03 | Warnings | O7TSZ97GEP |
| BIS II Tooth | PRECIPITATED CALCIUM CARBONATE, TOCOPHEROL ACETATE, ALUMINIUM CHLOROHYDROXY ALLANTOINATE, DIBASIC CALCIUM PHOSPHATE HYDRATE | Jewoo Medical CO.,LTD | 49f942e6-ceef-5505-e063-6394a90a113f | 2026-02-03 | Warnings | O7TSZ97GEP |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Teva Pharmaceuticals USA, Inc. | 83f4acc1-697a-4770-b554-1b9a8fb5de74 | 2026-01-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL | LISINOPRIL | RedPharm Drug, Inc. | 4f08cfc9-7afc-33aa-e054-00144ff88e88 | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | E7199S1YWR |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | e842fa14-b18e-4463-9bf1-a1c8700fe33c | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 686a5743-adc9-4729-9dbf-5cbc2c23897a | 2026-01-19 | Warnings, Adverse reactions | 0J48LPH2TH |
| olmesartan medoxomil-hydrochlorothiazide | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | AvKARE | 017bc6a3-5b3d-2381-e063-6394a90abece | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Coupler LLC | 44fd38d2-cb8b-d0e8-e063-6294a90a994e | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | AvKARE | 05ba1369-6484-75d4-e063-6294a90a63e4 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | A-S Medication Solutions | c2396dd4-faf2-447c-bda5-2362dbbbe352 | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | ANDA076230 197887 E7199S1YWR 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | A-S Medication Solutions | 22036b58-c1fe-45b5-ae08-93fdaf716528 | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | ANDA076230 197887 E7199S1YWR 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 90bb2207-2eaf-495b-a222-c69d4db9e7a3 | 2026-01-14 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.